BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 17414958)

  • 1. Macrophages and their products in rheumatoid arthritis.
    Szekanecz Z; Koch AE
    Curr Opin Rheumatol; 2007 May; 19(3):289-95. PubMed ID: 17414958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on cytokines in rheumatoid arthritis.
    Brennan F; Beech J
    Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance.
    Szekanecz Z; Szegedi G; Koch AE
    J Investig Med; 1998 Feb; 46(2):27-41. PubMed ID: 9549225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Understanding rheumatoid arthritis].
    Sibilia J; Sordet C; Mrabet D; Wachsmann D
    Rev Prat; 2005 Dec; 55(19):2134-42. PubMed ID: 16544924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X; Oppenheim JJ; Howard OM
    Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cells and osteoclasts are responsible for exacerbated collagen-induced arthritis in interferon-beta-deficient mice.
    Treschow AP; Teige I; Nandakumar KS; Holmdahl R; Issazadeh-Navikas S
    Arthritis Rheum; 2005 Dec; 52(12):3739-48. PubMed ID: 16320324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.
    Iwamoto T; Okamoto H; Toyama Y; Momohara S
    FEBS J; 2008 Sep; 275(18):4448-55. PubMed ID: 18662305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bibliography. Current World Literature. Rheumatoid arthritis.
    Curr Opin Rheumatol; 2007 May; 19(3):319-31. PubMed ID: 17489150
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
    Vandooren B; Noordenbos T; Ambarus C; Krausz S; Cantaert T; Yeremenko N; Boumans M; Lutter R; Tak PP; Baeten D
    Arthritis Rheum; 2009 Apr; 60(4):966-75. PubMed ID: 19333931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of chemokines in the pathogenesis of rheumatoid arthritis].
    Nanki T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():195-9. PubMed ID: 15799345
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemokines, a new family of cytokines in inflammatory cell recruitment].
    Martínez Martínez CM; Hernández Pando R
    Rev Invest Clin; 1999; 51(4):255-68. PubMed ID: 10546507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines and their receptors in rheumatoid arthritis: future targets?
    Koch AE
    Arthritis Rheum; 2005 Mar; 52(3):710-21. PubMed ID: 15751074
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of an ex vivo cellular model of rheumatoid arthritis: critical role of CD14-positive monocyte/macrophages in the development of pannus tissue.
    Nozaki T; Takahashi K; Ishii O; Endo S; Hioki K; Mori T; Kikukawa T; Boumpas DT; Ozaki S; Yamada H
    Arthritis Rheum; 2007 Sep; 56(9):2875-85. PubMed ID: 17763413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
    Szekanecz Z; Koch AE; Tak PP
    Neth J Med; 2011 Sep; 69(9):356-66. PubMed ID: 21978977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.
    Veale DJ; Fearon U
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):941-7. PubMed ID: 16980216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis.
    Santos LL; Morand EF
    Wien Med Wochenschr; 2006 Jan; 156(1-2):11-8. PubMed ID: 16465610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation.
    Jacques C; Gosset M; Berenbaum F; Gabay C
    Vitam Horm; 2006; 74():371-403. PubMed ID: 17027524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.
    Haringman JJ; Oostendorp RL; Tak PP
    Expert Opin Emerg Drugs; 2005 May; 10(2):299-310. PubMed ID: 15934868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.